Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mauro Cesar Dufrayer"'
Autor:
Mauro Cesar Dufrayer, Yasmine Massaro Carneiro Monteiro, Fabianne Altruda de Moraes Costa Carlesse, Fabrizio Motta, Liane Esteves Daudt, Mariana Bohns Michalowski
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss 4, Pp 473-482 (2023)
Introduction: The treatment of acute lymphoblastic leukemia (ALL) has evolved in recent decades, reaching an overall survival rate close to 90%. Currently, approximately 4% of patients with ALL die from secondary complications of chemotherapy. Among
Externí odkaz:
https://doaj.org/article/dfbff591c0164a3c80c8ca59784718a4
Autor:
Mauro Cesar Dufrayer, Ciliana Rechenmacher, Clarice Franco Meneses, Yasmine Massaro Carneiro Monteiro, Fabianne Altruda de Moraes Costa Carlesse, Fabrizio Motta, Liane Esteves Daudt, Mariana Bohns Michalowski
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 27, Iss 2, Pp 102745- (2023)
Background: Despite high cure rates, treatment-related mortality in children with acute lymphoblastic leukemia (ALL) remains significant. About 4% of patients die during remission induction therapy and approximately two-thirds of treatment-related de
Externí odkaz:
https://doaj.org/article/25c7cd69bca545468806c86851c941c3
Autor:
Mauro Cesar Dufrayer, Yasmine Massaro Carneiro Monteiro, Fabianne Altruda de Moraes Costa Carlesse, Fabrizio Motta, Liane Esteves Daudt, Mariana Bohns Michalowski
Publikováno v:
Hematology, Transfusion and Cell Therapy.
The treatment of acute lymphoblastic leukemia (ALL) has evolved in recent decades, reaching an overall survival rate close to 90%. Currently, approximately 4% of patients with ALL die from secondary complications of chemotherapy. Among these complica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c29512872cb5132a37151b835e5cc27
https://doi.org/10.1016/j.htct.2022.09.1279
https://doi.org/10.1016/j.htct.2022.09.1279